SYMPROIC

Peak

naldemedine

NDAORALTABLET
Approved
Mar 2017
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
May 13, 2033
87 months away
Patent Expiry
May 13, 2033

Patent Records (5)

Patent #ExpiryTypeUse Code
RE46375
Oct 5, 2026
SubstanceProduct
U-1185
RE46365
Feb 24, 2031
SubstanceProduct
—
9108975
Nov 11, 2031
SubstanceProduct
—
10952968
May 13, 2033
SubstanceProduct
—
12350377
May 13, 2033
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers